Intelligence Platform

Patents

Browse 405 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

patent

US 6844320

Treatment of preeclampsia, toxemia and preterm labor with combination of progestational ag

The Board of Regents of the University of Texas System · Granted Tue Jan 18 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 13 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6825323

Compositions for treatment of hemorrhaging with activated factor VIIa in combination with

The United States of America as represented by the Secretary of the Army · Granted Tue Nov 30 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 25 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6809075

Elastin peptide analogs and uses of same incombination with skin enhancing agents

Connective Tissue Imagineering, LLC · Granted Tue Oct 26 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 21 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6777389

Cosmetic or dermatological use of 7-hydroxylated steroids in combination with elastin deri

Connective Tissue Imagineering, LLC · Granted Tue Aug 17 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 12 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6759408

Combination regimens using progesterone receptor modulators

Ligand Pharmaceuticals Incorporated · Granted Tue Jul 06 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 01 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6630124

Combination therapy with VIP antagonist

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Oct 07 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 02 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6613757

COMBINATION OF PROSTACYCLIN WITH AN ESTROGEN OR PROGESTIN FOR THE PREVENTION AND TREATMENT

The Board of Regents of the University of Texas System · Granted Tue Sep 02 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 28 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6582699

Combination vaccine for enhancing immunity against brucellosis

Her Majesty the Queen in right of Canada, as represented by the Minister of National Defence in her Brittanic Majesty's Government of the United Kingdom of Great Britain and Northern Ireland · Granted Tue Jun 24 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 19 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6579857

Combination cancer therapy comprising adenosine and deaminase enzyme inhibitors

EVANSTON NORTHWESTERN HEALTHCARE RESEARCH INSTITUTE · Granted Tue Jun 17 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 12 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6528284

Polynucleotides encoding proteins mediating switch recombination

The Regents of the University of California · Granted Tue Mar 04 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 27 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6503939

Combination regimens using 3,3-substituted indoline derivatives

Ligand Pharmaceuticals Incorporated · Granted Tue Jan 07 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 02 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6444668

Combination regimens using progesterone receptor modulators

Ligand Pharmaceuticals Incorporated · Granted Tue Sep 03 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 29 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6423699

Combination therapies using benzimidazolones

Ligand Pharmaceuticals Incorporated · Granted Tue Jul 23 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 18 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6410603

Active topical skin protectants using combinations of reactive nanoparticles and polyoxome

The United States of America as represented by the Secretary of the Army · Granted Tue Jun 25 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 20 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6333313

Clinical use of oxytocin alone or in combination to treat bone disorders

The Board of Regents of the University of Texas System · Granted Tue Dec 25 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 20 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6329416

Combination regimens using 3,3-substituted indoline derivatives

Ligand Pharmaceuticals Incorporated · Granted Tue Dec 11 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 06 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6258845

DFMO and sulindac combination in cancer chemoprevention

Arizona Board of Regents on Behalf of the University of Arizona · Granted Tue Jul 10 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 05 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6203787

Treating tumors using implants comprising combinations of allogeneic cells

The Regents of the University of California · Granted Tue Mar 20 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 15 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6147060

Treatment of carcinomas using squalamine in combination with other anti-cancer agents

Magainin Pharmaceuticals Inc. · Granted Tue Nov 14 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 09 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6040340

Implantation rates after in vitro fertilization, treatment of infertility and early pregna

The Board of Regents, Univ. of Texas System · Granted Tue Mar 21 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 16 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6028106

Treatment of urinary incontinence with nitric oxide synthase substrates and/or nitric oxid

Board of Regents, The Univ. of TX System · Granted Tue Feb 22 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 17 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired